Generic Name and Formulations:
Rifabutin 150mg; hard-gel caps.
Indications for MYCOBUTIN:
Prevention of disseminated Mycobacterium avium complex (MAC) disease in advanced HIV infection.
≥18yrs: 300mg once daily. If inclined to GI upset, may give 150mg twice daily with food. Severe renal impairment (CrCl <30mL/min), concomitant amprenavir, indinavir, or nelfinavir: reduce rifabutin dose by 50%. Concomitant ritonavir, fosamprenavir/ritonavir, lopinavir/ritonavir, saquinavir/ritonavir, tipranavir/ritonavir: reduce rifabutin dose by 75% (to max 150mg every other day or 3 times per week).
<18yrs: not established.
Active tuberculosis: do not administer. Evaluate and test for tuberculosis before and during therapy; treat with combination antituberculosis regimen if active disease occurs. Suspend therapy if uveitis is suspected. Do hematologic tests periodically. May stain body secretions and contact lenses. Moderate-to-severe hepatic impairment. Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
Concomitant delavirdine, voriconazole: not recommended. Antagonizes dapsone, sulfamethoxazole-trimethoprim, zidovudine, oral contraceptives (change or use additional nonhormonal birth control methods) or drugs that are metabolized by CYP3A enzymes (eg, itraconazole, clarithromycin, saquinavir, posaconazole). Potentiated by CYP3A inhibitors (eg, fluconazole, clarithromycin, posaconazole).
Discolored urine, GI upset, abdominal pain, dyspepsia, fever, myalgia, rash, taste perversion, neutropenia, thrombocytopenia, leukopenia; rare: myositis, uveitis.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics